Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: A large, single-institution retrospective analysis

Breast Cancer Research and Treatment

Volumn 139, Issue 2, 2013, Pages 497-506

  Perez, Carmen A ^a   Zumsteg, Zachary S ^a   Gupta, Gaorav ^a   Morrow, Monica ^a   Arnold, Brittany ^a   Patil, Sujata M ^a   Traina, Tiffany A ^a   Robson, Mark E ^a   Wen, Yong H ^a   McCormick, Beryl ^a   Powell, Simon N ^a   Ho, Alice Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Outcomes; Race; Recurrence; Triple negative breast cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; NEGRO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST NEOPLASMS; YOUNG ADULT;

EID: 84878768577     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2550-x     Document Type: Article

References (27)

1. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363:1938-1948
2. Reis-Filho JS, Tutt AN (2008) Triple negative tumours: a critical review. Histopathology 52:108-118
3. Morris GJ, Naidu S, Topham AK et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 110:876-884
4. Duffy SW, Bowen RL, Ryan DA, et al (2008) Reply: early onset of breast cancer in black British women - how reliable are the findings? Br J Cancer. doi: 10.1038/sj.bjc.6604626
5. Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502
6. Lin NU, Vanderplas A, Hughes ME et al (2012) Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 118:5463-5472
7. Lund MJ, Trivers KF, Porter PL et al (2009) Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113:357-370
8. Greene FL, American Joint Committee on Cancer, American Cancer Society (2002) AJCC cancer staging manual, 6th edn. Springer, New York
9. Hudis CA, Barlow WE, Costantino JP et al (2007) Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol 25:2127-2132
10. Smith GL, Shih YC, Xu Y et al (2010) Racial disparities in the use of radiotherapy after breast-conserving surgery: a National Medicare Study. Cancer 116:734-741
11. Edwards-Bennett SM, Jacks LM, McCormick B et al (2011) Patterns of utilization of adjuvant radiotherapy and outcomes in black women after breast conservation at a large multidisciplinary cancer center. Int J Radiat Oncol Biol Phys 80:1102-1108
12. La Vecchia C, Giordano SH, Hortobagyi GN et al (2012) Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist 16:726-729
13. Chlebowski RT, McTiernan A, Wactawski-Wende J et al (2012) Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol 30:2844-2852
14. Tammemagi CM, Nerenz D, Neslund-Dudas C et al (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294:1765-1772
15. Lu Y, Ma H, Malone KE et al (2011) Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol 29:3358-3365
16. Christiansen N, Chen L, Gilmore J et al (2012) Association between African American race and outcomes in patients with nonmetastatic triple-negative breast cancer: a retrospective analysis by using results from the Georgia Cancer Specialist Database. Clin Breast Cancer 12:270-275
17. Chang Y, Schechter CB, van Ravesteyn NT et al (2012) Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality. Breast Cancer Res Treat 136:823-835
18. Moran MS, Yang Q, Harris LN et al (2008) Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer. Cancer 113:2565-2574
19. Pierce L, Fowble B, Solin LJ et al (1992) Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome. Cancer 69:2831-2841
20. Nicolaou NFB, Hanlon A (1999) The impact of regional lymphatic irradiation and of the extent of axillary lymph node dissection on regional control in patients with early-stage, node-positive breast cancer, treated with breast-conserving therapy. Proc Am Soc Clin Oncol 18:266
21. Dawood S, Broglio K, Kau SW et al (2009) Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol 27:220-226
22. Chu QD, Henderson AE, Ampil F et al (2012) Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity. Int J Breast Cancer 2012:764570
23. Bayraktar S, Gutierrez-Barrera AM, Liu D et al (2011) Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations. Breast Cancer Res Treat 130:145-153
24. Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D et al (2011) Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 117:3658-3669
25. Kim MJ, Ro JY, Ahn SH et al (2006) Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol 37:1217-1226
26. Zhao J, Liu H, Wang M et al (2009) Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol 100:89-94
27. Whelan TJ, Olivotto I, Ackerman I, Chapman JW, Chua B, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Craighead P, Nolan MC, Bowen J, McCready DR, Pritchard KI, Levine MN, Parulekar W (2011) NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. 2011 ASCO Annual Meeting. J Clin Oncol 29